||PTC596 is an orally active and selective inhibitor of B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1).
||PTC-028 selectively suppresses cancer cells whereas normal cells remain unaffected. PTC-028 is an orally bioavailable inhibitor of stem cell factor BMI-1 in ovarian cancer. The dep
||XMD8-92 is an effective and specific BMK1/ERK5 inhibitor (Kd: 80 nM).
||PTC-209 is a potent and selective BMI-1 inhibitor.
||PRT4165 is a potent inhibitor of PRC1-mediated H2A ubiquitylation.
||PTC-209 HBr is the hydrobromide salt of PTC-209, which is a potent and selective BMI-1 inhibitor with IC50 of 0.5 μM, and results in irreversible reduction of cancer-initiating ce